Grey Fox Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Grey Fox Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$8.72K	Buy
2023 Q2	–	Sell
2023 Q1	$19.6K	Sell
2022 Q4	$31.3K	Buy